ArticleMethodsX2024

Additive toxicity arising from combined use of immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with renal or endometrial carcinoma: Protocol for a rapid systematic review.

Shannon E Kelly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.